首页
400-620-6333
药靶抗体
-
Tafasitamab (anti-CD19)关联靶标: CD19种属反应性: Cynomolgus monkey,Human,Rhesus Macaque 亚型: Human IgG1偶联: UnconjugatedCAS号 : 1422527-84-1
-
Envafolimab (anti-PD-L1)关联靶标: CD274种属反应性: Cynomolgus monkey,Human 亚型: VHH偶联: UnconjugatedCAS号 : 2102192-68-5
-
Talquetamab (anti-GPRC5D)关联靶标: GPRC5D种属反应性: Cynomolgus monkey,Human,Mouse 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 2226212-40-2
-
Ibalizumab (anti-CD4)关联靶标: CD4种属反应性: Cynomolgus monkey,Human 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 680188-33-4
-
Tiragolumab (anti-TIGIT)关联靶标: TIGIT种属反应性: Cynomolgus monkey,Human,Rabbit 亚型: Human IgG1偶联: UnconjugatedCAS号 : 1918185-84-8
-
Magrolimab (anti-CD47)关联靶标: CD47种属反应性: Human,Mouse 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 2169232-81-7
-
Spartalizumab (anti-PD-1)关联靶标: PDCD1种属反应性: Cynomolgus monkey,Human 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 1935694-88-4
-
Ofatumumab (anti-CD20)关联靶标: MS4A1种属反应性: Cynomolgus monkey,Human 亚型: Human IgG1宿主种属: Human 克隆号: Ofabio 偶联: UnconjugatedCAS号 : 679818-59-8
-
-
Evolocumab(anti-PCSK9)关联靶标: PCSK9种属反应性: Cynomolgus monkey,Human,Mouse 亚型: Human IgG2偶联: UnconjugatedCAS号 : 1256937-27-5 Compound CID : 168010177IUPAC Name: 2-butylimino-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;2-(cyclopropylmethylimino)-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;2-ethylimino-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;3-[1-(4-fluorophenyl)ethyl]-2-(3-hydroxypropylimino)-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;3-[1-(4-fluorophenyl)ethyl]-2-methoxy-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazol-4-oneSMILES: CCCCN=C1NC(=CC2=CC(=C(C=C2)N3C=C(N=C3)C)OC)C(=O)N1C(C)C4=CC=C(C=C4)F.CCN=C1NC(=CC2=CC(=C(C=C2)N3C=C(N=C3)C)OC)C(=O)N1C(C)C4=CC=C(C=C4)F.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=NCCCO)N3)C(C)C4=CC=C(C=C4)F)OC.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=NCC4CC4)N3)C(C)C5=CC=C(C=C5)F)OC.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=N3)OC)C(C)C4=CC=C(C=C4)F)OCInChIKey: PUHBRGRYFZDQIV-UHFFFAOYSA-NInChI: InChI=1S/C27H28FN5O2.C27H30FN5O2.C26H28FN5O3.C25H26FN5O2.C24H23FN4O3/c1-17-15-32(16-30-17)24-11-6-20(13-25(24)35-3)12-23-26(34)33(27(31-23)29-14-19-4-5-19)18(2)21-7-9-22(28)10-8-21;1-5-6-13-29-27-31-23(26(34)33(27)19(3)21-8-10-22(28)11-9-21)14-20-7-12-24(25(15-20)35-4)32-16-18(2)30-17-32;1-17-15-31(16-29-17)23-10-5-19(14-24(23)35-3)13-22-25(34)32(26(30-22)28-11-4-12-33)18(2)20-6-8-21(27)9-7-20;1-5-27-25-29-21(24(32)31(25)17(3)19-7-9-20(26)10-8-19)12-18-6-11-22(23(13-18)33-4)30-14-16(2)28-15-30;1-15-13-28(14-26-15)21-10-5-17(12-22(21)31-3)11-20-23(30)29(24(27-20)32-4)16(2)18-6-8-19(25)9-7-18/h6-13,15-16,18-19H,4-5,14H2,1-3H3,(H,29,31);7-12,14-17,19H,5-6,13H2,1-4H3,(H,29,31);5-10,13-16,18,33H,4,11-12H2,1-3H3,(H,28,30);6-15,17H,5H2,1-4H3,(H,27,29);5-14,16H,1-4H3
-
Leronlimab (anti-CCR5)关联靶标: CCR5种属反应性: Human,Rhesus Macaque 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 674782-26-4
-
